QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus 期刊论文 JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 卷号: 70, 期号: 7 作者:  Zhang, Hong;  Zhu, Xiaoxue;  Li, Qingmei;  Lou, Jinfeng;  Sun, Jixuan 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05 direct-acting antiviral agent  genotype 1  hepatitis C  nonstructural protein 5A  pharmacokinetics   Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]. 期刊论文 Chinese journal of hepatology, 2018, 卷号: 26, 页码: 359-364 作者:  Wei L;  Cheng J;  Luo J;  Li Z P;  Duan J L 收藏  |  浏览/下载：13/0  |  提交时间：2019/11/19 Direct-acting antiviral agent  Safety  Hepatitis C, chronic   Current treatment of chronic hepatitis C in China: Dilemma and potential problems 期刊论文 WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 卷号: 22, 期号: [db:dc_citation_issue], 页码: 4615-4618 作者:  Han, Qun-Ying;  Liu, Zheng-Wen 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/02 Direct-acting antiviral agent  China  Treatment  Generics  Hepatitis C virus infection   Potential role for statins in the treatment of chronic HCV infection 期刊论文 FUTURE VIROLOGY, 2013, 卷号: 8, 期号: [db:dc_citation_issue], 页码: 727-729 作者:  Zhu, Qianqian;  Han, Qunying;  Liu, Zhengwen 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/10 IFN-  chronic hepatitis C  direct-acting antiviral  treatment  host-targeting agent  statin  ribavirin   Kaposi's sarcoma-associated herpesvirus-encoded lana down-regulates il-22r1 expression through a cis-acting element within the promoter region 期刊论文 Plos one, 2011, 卷号: 6, 期号: 4, 页码: 10 作者:  Su, Ling;  Liao, Qingjiao;  Wu, Yang;  Chen, Xulin 收藏  |  浏览/下载：13/0  |  提交时间：2019/05/09